Skip to main content
Clinical Trials/CTRI/2016/12/007585
CTRI/2016/12/007585RecruitingPhase 2

Phase II randomized Controlled trial of postoperative Intensity modulated Radiotherapy (IMRT) in locally Advanced Thyroid Cancers. - THYRO-RT

Tata Memorial Hospital Intramural fundin0 sites72 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • A) All patients of thyroid cancer (papillary/follicular/poorly differentiated) who have undergone total/completion thyroidectomy at our institute and having at least two of the following features (listed below) intra-operatively and/or on histopathology
  • 1.Gross extrathyroidal spread into soft tissues of the neck, trachea, esophagus, recurrent laryngeal nerve (constituting stage T4a)
  • 2.R1/ shave resections (minimal residual disease)
  • 3.R2 resections (gross residual disease)
  • 4.Multiple lymph nodes positive( >2) with perinodal extension at level VI
  • B) Normal baseline haematological and biochemical parameters

Exclusion Criteria

  • 1.Anaplastic or medullary thyroid cancer
  • 2.Previous history of radiation
  • 3.Pregnancy
  • 4. < 18 years
  • 5.Patient unwilling to participate in the study

Investigators

Sponsor
Tata Memorial Hospital Intramural fundin

Similar Trials